MANDOS LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

4

Active:0

Completed:1

Trial Phases

2 Phases

Phase 2:3

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2

3 (75.0%)

Phase 3

1 (25.0%)

Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease

Phase 2

Terminated

Conditions: Niemann-Pick Disease, Type C

Interventions: Drug: Adrabetadex

First Posted Date: 2021-07-12

Last Posted Date: 2023-08-29

Lead Sponsor: Mandos LLC

Target Recruit Count: 66

Registration Number: NCT04958642

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Children's Hospital of Orange County: CHOC Children's, Orange, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 27 locations

Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1

Phase 2

Terminated

Conditions: Niemann-Pick Disease, Type C

Interventions: Drug: VTS-270

First Posted Date: 2019-03-19

Last Posted Date: 2023-12-26

Lead Sponsor: Mandos LLC

Target Recruit Count: 2

Registration Number: NCT03879655

Locations: 🇨🇷
Hospital Clinica Biblica, San José, Costa Rica

Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System

Phase 3

Terminated

Conditions: Niemann-Pick Type C Disease

Interventions: Drug: Adrabetadex

First Posted Date: 2018-08-23

Last Posted Date: 2024-01-17

Lead Sponsor: Mandos LLC

Target Recruit Count: 27

Registration Number: NCT03643562

Locations: 🇺🇸
University of Arkansas System, Little Rock, Arkansas, United States
🇺🇸
Loma Linda University Health System, Loma Linda, California, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States

and more 14 locations

VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease

Phase 2

Completed

Conditions: Niemann-Pick Disease, Type C

First Posted Date: 2015-08-28

Last Posted Date: 2023-02-22

Lead Sponsor: Mandos LLC

Target Recruit Count: 56

Registration Number: NCT02534844

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Children's Hospital of Orange County, Orange, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 26 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.